Acorah Software Products - Accounts Production 15.0.400 true true 31 December 2022 1 April 2022 false true No description of principal activity 1 January 2023 31 December 2023 31 December 2023 08952907 Mr Howard Shapland iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08952907 2022-12-31 08952907 2023-12-31 08952907 2023-01-01 2023-12-31 08952907 frs-bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 08952907 frs-bus:FilletedAccounts 2023-01-01 2023-12-31 08952907 frs-bus:Micro-entities 2023-01-01 2023-12-31 08952907 frs-bus:EntityHasNeverTraded 2023-01-01 2023-12-31 08952907 frs-bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 08952907 frs-bus:Director1 2023-01-01 2023-12-31 08952907 2022-03-31 08952907 2022-12-31
Registered number: 08952907
Aquarius Healthcare Ltd
Unaudited Financial Statements
For The Year Ended 31 December 2023
GLX Accounting Limited
ICAEW Chartered Accountants
69-75 Thorpe Road
Norwich
NR1 1UA
Balance Sheet
Registered number: 08952907
31 December 2023 31 December 2022
£ £
Current assets 1 1
NET CURRENT ASSETS 1 1
TOTAL ASSETS LESS CURRENT LIABILITIES 1 1
NET ASSETS 1 1
CAPITAL AND RESERVES 1 1

Notes

1. General Information
Aquarius Healthcare Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 08952907 . The registered office is C/O GLX, 69-75 Thorpe Road, Norwich, NR1 1UA.
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr Howard Shapland
Director
5th August 2024